AACE: Saroglitazar found safe, effective for management of diabetic dyslipidemiaJune 10, 2015Lipid DisordersDiabetes
ELIXA trial: No cardiovascular risk with GLP-1 receptor agonist lixisenatideJune 9, 2015DiabetesLipid Disorders
Bariatric surgery, lifestyle intervention had similar effects on hemoglobin A1cJune 8, 2015DiabetesObesity
OARSI: Chronic conditions complicate osteoarthritis treatment, complianceMay 29, 2015DiabetesLipid DisordersHypertensionObesity
Metabolic syndrome incidence may be stabilizingMay 19, 2015Lipid DisordersDiabetesObesityHypertension
